StockData
Agenus Inc logo

Agenus Inc (AGEN) stock

AGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/30
$6.21−0.08 (-1.27%)

Close on Nov 17, 2026Market cap $279.58MP/E –Yield –

Agenus cash

Cash and short-term investments held at the end of each period.

Agenus's cash was $18.74M at Jun 30, 2026. For fiscal 2025 it was $3.00M, down 92.6% from the year before. Over ten years it grew -33.3% a year on average. The highest annual figure on record is $306.90M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.00M-92.6%
FY2024Dec 31, 2024$40.40M-46.9%
FY2023Dec 31, 2023$76.10M-60.7%
FY2022Dec 31, 2022$193.40M-37.0%
FY2021Dec 31, 2021$306.90M+207.3%
FY2020Dec 31, 2020$99.87M+61.6%
FY2019Dec 31, 2019$61.81M+16.4%
FY2018Dec 31, 2018$53.10M-11.8%
FY2017Dec 31, 2017$60.20M-21.2%
FY2016Dec 31, 2016$76.40M-55.5%
FY2015Dec 31, 2015$171.70M+326.9%
FY2014Dec 31, 2014$40.22M+47.1%
FY2013Dec 31, 2013$27.35M+27.4%
FY2012Dec 31, 2012$21.47M+99.7%
FY2011Dec 31, 2011$10.75M-45.7%
FY2010Dec 31, 2010$19.78M-1.4%
FY2009Dec 31, 2009$20.07M-18.0%
FY2008Dec 31, 2008$24.47M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$18.74M+97.2%
Q1 FY2026Mar 31, 2026$35.00M+89.2%
Q4 FY2025Dec 31, 2025$3.00M-92.6%
Q3 FY2025Sep 30, 2025$3.50M-92.2%
Q2 FY2025Jun 30, 2025$9.50M-89.9%
Q1 FY2025Mar 31, 2025$18.50M-65.0%
Q4 FY2024Dec 31, 2024$40.40M-46.9%
Q3 FY2024Sep 30, 2024$44.80M-57.9%
Q2 FY2024Jun 30, 2024$93.70M-40.7%
Q1 FY2024Mar 31, 2024$52.90M-72.0%
Q4 FY2023Dec 31, 2023$76.10M-60.7%
Q3 FY2023Sep 30, 2023$106.30M-51.3%
Q2 FY2023Jun 30, 2023$157.90M-33.7%
Q1 FY2023Mar 31, 2023$189.20M-28.0%
Q4 FY2022Dec 31, 2022$193.40M-37.0%
Q3 FY2022Sep 30, 2022$218.20M-16.6%
Q2 FY2022Jun 30, 2022$238.30M+224.0%
Q1 FY2022Mar 31, 2022$262.70M+120.1%
Q4 FY2021Dec 31, 2021$306.90M+207.3%
Q3 FY2021Sep 30, 2021$261.50M+129.1%
Q2 FY2021Jun 30, 2021$73.54M-7.1%
Q1 FY2021Mar 31, 2021$119.37M+29.3%
Q4 FY2020Dec 31, 2020$99.87M+61.6%
Q3 FY2020Sep 30, 2020$114.14M+22.4%
Q2 FY2020Jun 30, 2020$79.17M-35.0%
Q1 FY2020Mar 31, 2020$92.28M-41.7%
Q4 FY2019Dec 31, 2019$61.81M+16.4%
Q3 FY2019Sep 30, 2019$93.27M+102.0%
Q2 FY2019Jun 30, 2019$121.72M+182.0%
Q1 FY2019Mar 31, 2019$158.31M+202.4%
Q4 FY2018Dec 31, 2018$53.10M-11.8%
Q3 FY2018Sep 30, 2018$46.17M-34.1%
Q2 FY2018Jun 30, 2018$43.16M-55.4%
Q1 FY2018Mar 31, 2018$52.35M-57.7%
Q4 FY2017Dec 31, 2017$60.20M-21.2%
Q3 FY2017Sep 30, 2017$70.10M-26.5%
Q2 FY2017Jun 30, 2017$96.80M–
Q1 FY2017Mar 31, 2017$123.80M–
Q4 FY2016Dec 31, 2016$76.40M–
Q3 FY2016Sep 30, 2016$95.40M–

More Agenus figures

See a number that looks wrong?